BlueCloud follows the Uber model to streamline connections

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/ bogdan kosanovic)
(Image: Getty/ bogdan kosanovic)

Related tags: Research, Site selection, Clinical trial, CRO, Health care, CRO market, research network

BlueCloud by HealthCarePoint releases DDIT mechanisms to create an Uber-like service for the health care industry – connecting providers and consumers, such a sponsors and CROs.

BlueCloud, an independent network system​ for health care and clinical research created by HealthCarePoint, this week announced the addition of its delivery, distribution, implementation, and tracking (DDIT) mechanisms.

President of BlueCloud Al Pacino told us that the addition of the DDIT applications to its global system allows the collaborative network to operate like Uber: Connecting providers like investigative trial sites, to industry consumers such as sponsors and contract research organizations (CROs).

The network also added the DDIT mechanisms in an aim to “modernize the health care and clinical research ecosystem using basic business and compliance principles and modern technology models, by simply connecting industry consumers,” ​Pacino said. Each mechanism or application is designed to streamline a component of clinical research

The delivery and distribution mechanisms within the BlueCloud system enable consumers to find the products, services, and technologies needed for clinical research through authorized channels. It also provides patient maps to help locate potential clinical trial participants, among other applications and tools to help connect providers and consumers.

“Whenever the sponsors need to identify investigative sites for their clinical trial they should not have to pay for the list of investigative sites or the directories of thousands of professionals at the sites in order to do site screening and have site accessibility, it’s free to the sponsor as a consumer.

"Sponsors then use the BlueCloud DDIT on-demand mechanisms to properly identify the investigative sites that they’re going to choose for their clinical. Once they chose their sites, just like Uber once we chose our driver, sponsors are able to connect to their chosen sites immediately using their own BlueCloud system and perform site competencies, feasibility and other screening activities at no cost to the sponsor,” ​Pacino explained.

Additionally, a centralized global tracking system keeps tabs on regulatory compliance.

Pacino said, “The BlueCloud System looks to modernize all aspects of healthcare and clinical research not just creating a temporary solution for a single problem. By modernizing the complete ecosystem the industry can ultimately be sustainable - when opportunities are provided to every stakeholder – everyone win.”

Related news

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more